ASD THERAPEUTICS PARTNERS LLC has a total of 16 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2005. It filed its patents most often in Australia, EPO (European Patent Office) and Hungary. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are CATALYST THERAPEUTICS PTY LTD, PIRAMED LTD and DHANAK DASHYANT.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 4 | |
#2 | EPO (European Patent Office) | 2 | |
#3 | Hungary | 2 | |
#4 | United States | 2 | |
#5 | Canada | 1 | |
#6 | Hong Kong | 1 | |
#7 | India | 1 | |
#8 | Japan | 1 | |
#9 | New Zealand | 1 | |
#10 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Fuertes Huerta Ana | 14 |
#2 | Medina Padilla Miguel | 14 |
#3 | De Cristobal Blanco Javier | 10 |
#4 | Palomo Nicolau Francisco | 10 |
#5 | Herrero Santos Susana | 10 |
#6 | Martínez Montero Olga | 6 |
#7 | Domínguez Correa Juan Manuel | 6 |
#8 | Pérez De La Cruz Moreno María Ángeles | 6 |
#9 | Rodríguez Salguero Beatriz | 6 |
#10 | López Ogalla Javier | 6 |
Publication | Filing date | Title |
---|---|---|
EP2838888A1 | Thiadiazolidinediones as gsk-3 inhibitors | |
AU2005230392A1 | Thiadiazolidinones as GSK-3 inhibitors |